The Centers for Medicare & Medicaid Services yesterday updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.

For inpatient admissions occurring on or after Sept. 1, 2020, claims eligible for the 20% add-on will be required to have a positive COVID-19 laboratory test documented in patients’ medical records.

Read the AHA Special Bulletin for additional information on this policy’s importance to hospitals and health systems.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services June 26 issued its calendar year 2025 proposed rule for the home health prospective payment system, which…
Headline
The AHA submitted a letter to the Centers for Medicare & Medicaid Services June 7, commenting on the fiscal year 2025 proposed rule for the long-term care…
Headline
The AHA submitted comments June 5 on the Centers for Medicare & Medicaid Services’ inpatient prospective payment system proposed rule for fiscal year 2025…
Headline
The AHA commented May 28 on the Centers for Medicare & Medicaid Services’ proposed rule for the inpatient psychiatric facility prospective payment system…
Headline
AHA commented May 24 on the Centers for Medicare & Medicaid Services' proposed rules for the skilled nursing and inpatient rehabilitation facility…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…